R

Revenio Group Oyj
OMXH:REG1V

Watchlist Manager
Revenio Group Oyj
OMXH:REG1V
Watchlist
Price: 27 EUR -2.81% Market Closed
Market Cap: 718.1m EUR
Have any thoughts about
Revenio Group Oyj?
Write Note

Revenio Group Oyj
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Revenio Group Oyj
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
R
Revenio Group Oyj
OMXH:REG1V
Capital Expenditures
-€4.2m
CAGR 3-Years
-36%
CAGR 5-Years
-23%
CAGR 10-Years
-27%
M
Modulight Oyj
OMXH:MODU
Capital Expenditures
-€15.7m
CAGR 3-Years
-97%
CAGR 5-Years
-64%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Capital Expenditures
-€161.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Capital Expenditures
-€2.4m
CAGR 3-Years
-10%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Capital Expenditures
-€1.6m
CAGR 3-Years
-44%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Capital Expenditures
-€348k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-2%
No Stocks Found

Revenio Group Oyj
Glance View

Market Cap
718.1m EUR
Industry
Health Care

Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. The company is headquartered in Vantaa, Etela-Suomen and currently employs 184 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

REG1V Intrinsic Value
30.98 EUR
Undervaluation 13%
Intrinsic Value
Price
R

See Also

What is Revenio Group Oyj's Capital Expenditures?
Capital Expenditures
-4.2m EUR

Based on the financial report for Sep 30, 2024, Revenio Group Oyj's Capital Expenditures amounts to -4.2m EUR.

What is Revenio Group Oyj's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-27%

Over the last year, the Capital Expenditures growth was -55%. The average annual Capital Expenditures growth rates for Revenio Group Oyj have been -36% over the past three years , -23% over the past five years , and -27% over the past ten years .

Back to Top